Skip to main content
Premium Trial:

Request an Annual Quote

BioInform's Licensing Roundup: July and August's Software Deals

Premium

Takeda San Francisco has licensed Ariadne’s Pathway Studio software.

The biologics discovery arm of Takeda plans to use the software to support its therapeutics discovery for cancer, inflammatory disease, and metabolic disease.


ChemAxon said that the Broad Institute will license its platform, discovery toolkits, and desktop applications for institute-wide use.

Specifically, the Broad will use ChemAxon's technology, including the JChem toolkit, to support its small-molecule registration system and other aspects of its Chemical Biology Platform.


The Catholic Health Initiatives’ Institutes for Research and Innovation’s Center for Translational Research will use BioFortis's Labmatrix software as part of its personalized medicine research effort.

Labmatrix is a web-based software that lets users manage and integrate clinical, specimen, and molecular assay datasets and interface the data with other systems such as electronic medical records, genomic or proteomic databases, and laboratory information management systems.

As part of the agreement, the partners plan to integrate the software with in-network hospitals’ electronic medical records systems.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.